Innovate U.K. is a NPO that offers funding services to support science and technology innovations. The organization offers services and information on births, deaths, marriages, business, self-employed, childcare, parenting, citizenship, law, disabled persons, transportation, education, environment, housing, money, tax, travel, immigration, and jobs. Innovate U.K. is based in Swindon.
Programme Director of Industrial Strategy Challenge Fund
Will Drury
Executive Director, Digital and Technologies
Paul Gadd
Deputy Director
Dr. Tom Jenkins
Deputy Director
Scott James O'Brien
Director, Innovation Finance
Nigel Walker
Deputy Director, Lending and Investor Partnerships
Dave Wilkes
Director of Innovation Ecosystem
Past deals in United Kingdom
MediaCity Immersive Technologies Innovation Hub
Grant in 2025
MediaCity Immersive Technologies is a unique setting with the highest amount of creative, media, mix technology enterprises outside of London.
Paragraf
Grant in 2025
Paragraf Ltd. is a UK-based company specializing in the development of graphene technology and the production of two-dimensional materials. Established in 2015, Paragraf focuses on creating graphene-based electronic devices, including magnetic sensors and biosensors, that are designed to enhance technological performance in various sectors such as electronics, energy, research, automation, and healthcare. The company employs contamination-free technology to ensure the production of high-purity graphene products that meet commercial quality standards. Paragraf's innovations aim to optimize process control, improve quality assurance, and facilitate monitoring of environmental and health conditions, thereby contributing to advancements in green energy generation and other critical applications.
Tewke
Grant in 2024
Tewke is a London based company that was founded in 2020 developing technology to deliver energy savings through AI enabled home automation. Tewke's mission is to reduce energy consumption in homes whilst elevating everyone's living experience. Tewke's first product, Tap, is an intelligent light switch that can be installed into any home without rewiring. This acts as the backbone of Tewke's energy control and home automation platform, and has already won international awards, such as the Red Dot Design Award.
Altair
Grant in 2024
Altair Engineering, Inc. provides enterprise analytics, engineering, and on-demand computing software technologies. Its technology optimizes the analysis, management, and visualization of business and engineering information. The company's products include HyperWorks, an enterprise simulation solution for design exploration and decision-making; and PBS GridWorks, a software environment for grid, cluster, and on-demand computing. It also provides product development consultancy services, business intelligence software solutions, and solid state lighting products, as well as develops and markets industrial design/styling software. The company serves automotive, aerospace, government and defense, heavy equipment, consumer products, life and earth sciences, oil and gas, and financial services industries. It sells its products through resellers and distributors in North America, South America, Europe, Africa, Russia, Asia, and Australia. The company was founded in 1985 and is headquartered in Troy, Michigan. It has regional offices and locations in Australia, New Zealand, Brazil, Canada, China, France, Germany, India, Italy, Japan, Korea, Mexico, the Russian Federation, Sweden, the United Kingdom, Ireland, and the United States.
Medannex
Grant in 2024
MedAnnex Limited is a biotechnology company based in Edinburgh, United Kingdom, focused on developing innovative treatments for patients suffering from autoimmune diseases and cancers. Established in 2009, the company specializes in creating monoclonal antibodies, particularly annexuzlimab, which targets and inhibits annexin-A1. This therapeutic approach aims to modulate both the innate and adaptive immune systems, enhancing treatment options for physicians and improving patient outcomes. MedAnnex is committed to advancing first-in-class antibody therapies that can significantly benefit individuals affected by these challenging health conditions.
Marine Power Systems
Grant in 2024
Marine Power Systems Ltd. is a marine renewables technology development company based in Swansea, United Kingdom, established in 2008 by engineering graduates from Swansea University, Dr. Gareth Stockman and Dr. Graham Foster. The company focuses on the development and commercialization of innovative wave energy converters, including its flagship product, WaveSub, along with DualSub and WindSub devices. These converters operate under the sea's surface, adjusting their depth to optimize energy extraction and minimizing damage during severe weather conditions. By harnessing wave energy, Marine Power Systems aims to reduce the costs associated with energy generation from ocean waves, contributing to the renewable energy sector and promoting sustainable energy solutions.
Vector Photonics
Grant in 2024
Vector Photonics is a spin-out company from the University of Glasgow, located in Glasgow, Scotland, a notable center for optical and photonics innovation. The company specializes in developing advanced semiconductor laser technology aimed at enhancing data communications and additive manufacturing processes, including metal and plastic printing. Its innovative approach centers on photonic crystal surface-emitting lasers, which are cost-effective and emit light from their top surface, similar to vertical-cavity surface-emitting lasers (VCSELs). This design facilitates easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies, allowing various industries to seamlessly adopt this semiconductor laser technology into their operations.
LIfT BioSciences
Grant in 2024
LIfT BioSciences is a biotechnology company based in London, England, founded in 2016. The company specializes in a novel allogeneic innate immuno-cell therapy platform known as Neutrophil Only Leukocyte Infusion Therapy (N-LIfT). This platform enables the large-scale production of Immunomodulatory Alpha Neutrophils (IMANs) derived from induced pluripotent stem cells (iPSCs) for various therapeutic applications. LIfT BioSciences focuses on developing CAR neutrophil cell therapies that address the limitations of existing treatments for solid tumors. These therapies work by directly attacking tumors and indirectly enhancing the immune response, effectively transforming the tumor microenvironment to recruit additional immune cells for a more robust and lasting attack on the cancer. By employing proprietary enhancement media and genetic engineering, LIfT BioSciences aims to significantly increase the cancer-fighting capabilities of these engineered cells, potentially providing patients with greatly improved therapeutic outcomes.
GaitQ
Grant in 2024
GaitQ Limited, founded in 2019 and based in Oxfordshire, United Kingdom, specializes in developing a medical device aimed at assisting individuals with Parkinson's disease in overcoming freezing of gait. The company's product, known as the GaitThaw device, is small and portable, designed to utilize clinically proven sensory cues. These cues facilitate the re-establishment of the connection between the brain and the body, enabling patients to walk more smoothly and confidently.
Outfield
Grant in 2024
Outfield is an agritech company focused on transforming orchard management through its precision farming platform. By utilizing unmanned drones and advanced image recognition technology, Outfield collects and analyzes data to deliver actionable insights on key aspects such as fruit counts, blossom mapping, crop load management, and yield forecasting. This innovative approach significantly improves the accuracy of yield estimates, reducing common errors from 20% to less than 10%, thereby enhancing productivity and profitability for growers. The platform processes drone-captured images and returns detailed maps and insights to users within 24 hours, allowing for efficient decision-making. Currently, the service is being tested by growers in the UK, New Zealand, and South Africa, who have praised its flexibility and speed. Outfield aims to scale its operations, expand its offerings, and enter new market segments as it addresses the growing demand for sustainable and efficient fruit farming solutions.
NuKoKo
Grant in 2024
NuKoKo is a bean-to-bar manufacturing company specializing in cocoa-free chocolate. By utilizing ingredients sourced from the UK, the company has developed a patent-pending technology that allows for the production of a novel type of chocolate. This innovative product is designed to be healthier and has a significantly reduced environmental impact compared to traditional chocolate production methods. NuKoKo's offerings are characterized by low carbon emissions, low sugar content, and high protein, catering to consumers seeking sustainable and nutritious alternatives in the chocolate market.
Occuity
Grant in 2024
Occuity Ltd is a company based in Reading, United Kingdom, that focuses on the research, design, and manufacture of non-contact optical instruments for healthcare diagnostics and monitoring. Founded in 2019, it offers a range of handheld devices, including pachymeters, pupillometers, and keratometers, which are utilized in both human and veterinary optometry. These instruments employ light to analyze the eye, facilitating direct measurements that assist optometrists and ophthalmologists in diagnosing and monitoring various health conditions, such as diabetes and Alzheimer's disease. By providing innovative non-contact solutions, Occuity aims to enhance the effectiveness and accessibility of diagnostic and screening technologies in the healthcare sector.
University of Nottingham
Grant in 2024
The University of Nottingham is a prominent institution known for its comprehensive and research-led approach to education. It operates an international business school with campuses in the UK, China, and Malaysia, emphasizing strong ties to the corporate sector and delivering high-quality teaching programs. The business school is recognized for its influential research, particularly in areas such as banking and finance, entrepreneurship, innovation, and business sustainability. The university is financially secure and committed to enhancing the international experience for its students, preparing them for diverse intellectual, professional, and personal endeavors. Additionally, the University manages an endowment fund that supports scholarships, academic positions, and various research and public service initiatives.
SolasCure
Grant in 2024
SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on developing innovative solutions for patients with chronic wounds. Founded in 2017, the company is advancing its product Aurase, a hydrogel designed to facilitate wound debridement by removing dead, damaged, or infected tissue to enhance healing. Aurase incorporates a recombinant enzyme derived from maggots, leveraging biomimicry and evidence-based medicine to improve wound care outcomes. SolasCure aims to provide effective wound bed preparation across various healthcare settings, ultimately accelerating the healing process for individuals suffering from chronic wounds.
IXICO
Grant in 2024
IXICO is a UK-based company specializing in clinical trial services and technology focused on imaging endpoints for the pharmaceutical and biotechnology sectors. The company primarily operates in the fields of oncology and neurology, offering end-to-end imaging services that cater to various therapeutic areas, including Alzheimer's, Parkinson's, Huntington's disease, and other neurodegenerative conditions. IXICO supports clients throughout the entire clinical research journey, providing services for early and late-phase clinical development, post-marketing assessments, and consultancy. With a presence in multiple countries, including the United States, Switzerland, the Netherlands, and Ireland, IXICO collaborates with pharmaceutical companies, academia, and medical charities to advance the treatment of complex diseases.
Recap
Grant in 2024
Recap operates a cryptocurrency accounting platform designed to simplify tax compliance and portfolio management for users engaged in cryptocurrency transactions. The platform connects with users' accounts across various wallets, blockchains, and exchanges to facilitate portfolio tracking and tax calculation. By offering features such as end-to-end encryption and tax reporting tailored for the US and UK, Recap enables clients to gain clear insights into their cryptocurrency investments and optimize their tax positions. The user-friendly and privacy-focused app addresses the complexities of managing numerous transactions, making it easier for individuals to navigate the intricacies of crypto taxes.
Dragonfly Insulation
Grant in 2024
Dragonfly Insulation is a spin-out from Newcastle University focused on scaling up the production of aerogel materials through an innovative manufacturing process that emphasizes low energy consumption. The company specializes in creating synthetic nanostructured porous ceramic products designed to provide effective thermal insulation across various sectors, including aerospace, defense, marine, oil and gas, and construction. By simplifying the manufacturing process, Dragonfly Insulation aims to improve accessibility to advanced fire safety features in civil applications, catering to a diverse range of industry needs.
Brompton Bicycle
Grant in 2024
Brompton Bicycle is a manufacturer of folding bicycles based in West London, England. The company specializes in the design and production of the Brompton folding bike, catering to urban residents and commuters. In addition to its signature bicycles, Brompton offers a range of products including electric bikes, bags, clothing, helmets, and various bicycle parts and accessories. These products are available through a network of retail stores and an e-commerce platform, as well as through bike rental services. Brompton Bicycle promotes sustainable and healthy transportation options for its customers.
Optrical
Grant in 2024
Optrical Limited, founded in 2016 and headquartered in Rotherham, United Kingdom, specializes in the development and manufacturing of micro-optic elements. The company focuses on producing advanced micro-optic film products, primarily for LED and OLED lighting applications, as well as for optical anti-counterfeiting and traceability solutions. Their flagship products include Illumax, which enhances light extraction and management in lighting systems, and Authntrace, designed to provide authentication and traceability features. Optrical utilizes innovative designs and custom UV materials to create printed microstructures that effectively manipulate light, catering to various client needs in the optical sector.
Ultima Forma
Grant in 2024
Ultima Forma is a manufacturer based in England that specializes in producing lightweight, high-strength, multi-functional metallic engineering components. The company is focused on developing an innovative manufacturing process that enables the creation of complex 3D multi-material components with locally tailored nanoengineered characteristics. By offering customized solutions, Ultima Forma aims to redefine traditional manufacturing methods and deliver components with specific shapes and material properties, enhancing the performance and functionality of various applications.
Concr
Grant in 2024
Concr is a techbio company focused on enhancing cancer treatment by predicting patient responses to various therapies. Utilizing methods from astrophysics, Concr's innovative approach allows for iterative learning from diverse data sources throughout a drug's clinical journey, resulting in accurate multi-modal tumor models without relying on extensive data sets. Its cloud-native platform, FarrSight®, enables researchers to simulate clinical trials, predict therapeutic responses and biomarkers, and conduct standard bioinformatics analyses. This technology aims to identify optimal treatments for individual patients, reduce treatment resistance, and facilitate personalized cancer management. Headquartered in London with a subsidiary in Brisbane, Australia, Concr is backed by several investors, including the University of Cambridge Enterprise and Oncology Ventures.
CircKit
Seed Round in 2024
CircKit is the AI-driven B2B SaaS platform that empowers fashion & textiles brands to unlock new growth from circular design. Design sustainable products, make smarter material and production choices, measure and track social & environmental indicators, and meet urgent compliance with ease. By harmonising data and enabling collaborative working across teams, CircKit supports brands to reduce costs, increase profit & unlock revenue from circular design and lucrative end-of-life ‘closed loop’ initiatives. CircKit also powers one of the UK's largest sustainable lifestyle marketplaces, as the destination for brands to reach consumers of Fashion and lifestyle products (Beauty, Food & Drink, Home and Wellness)... __________ Veo® is the marketplace for sustainable lifestyle™. Veo took a tech-first approach to build the world's largest and most sustainable online shopping platform. We have solved the scalability problem inherent in large platforms, and created the lifestyle destination for conscious consumers to discover a world of unique, independent, sustainable brands all in one place. We thoroughly assess and vet all our products and brands, we do the research so you don't have to. That's why we've been Ethical Consumer's most ethical retailer for the last 3 consecutive years running and recognised as a global Top 5% Certified B Corporation, with a score of 130.6 and prestigious ‘Best For The World'. We developed our industry-leading assessment matrix which qualifies and approves the full life cycle of products from brands to join the platform. This instils critical consumer trust and assurance for becoming the world's largest, most sustainable lifestyle shopping platform. Our mission is to revolutionise retail, empowering businesses and consumers to embrace circular and regenerative consumption and production (SDG 12). __________ *most sustainable as Ethical Consumer's top-rated 'ethical online retailer' **largest by number of brands & SKUs
Legal Utopia
Grant in 2024
Legal Utopia is an innovative company dedicated to making legal services more accessible, affordable, and instantaneous for individuals across the UK. By leveraging artificial intelligence, Legal Utopia provides a platform that empowers users to identify their legal issues, comprehend them, and explore available options. The company's mission is to democratize access to legal information, ensuring that people from all backgrounds and circumstances can understand and address their common legal problems as needed. With a focus on user-friendly technology, Legal Utopia aims to transform the way individuals engage with the law, making the legal process simpler and fairer for everyone.
Mesenbio
Grant in 2024
Mesenbio is a preclinical biopharmaceutical company located at the University of York, specializing in cell-derived therapies. It employs a unique technique known as Cell Line Extracellular Vesicle Release (CLEVR), which enhances the development of treatments by addressing common challenges in extracellular vesicle therapy. The company is focused on creating innovative treatments for conditions such as arthritis, utilizing engineered human stem cells. By unlocking the potential of extracellular vesicles, Mesenbio aims to improve access to effective therapies for musculoskeletal diseases, thereby contributing to advancements in medical treatment.
University of Edinburgh
Grant in 2023
The University of Edinburgh, established in 1583, is the sixth-oldest university in the English-speaking world and one of Scotland's ancient universities. Recognized as one of the most prestigious institutions globally, it offers a diverse range of academic programs across various disciplines, including notable schools such as the Medical School and the Law School. The university is dedicated to excellence in teaching and research, attracting students and scholars from around the world. Its rich history and commitment to innovation make it a key player in higher education, contributing significantly to academic and societal advancements.
Holly Health
Seed Round in 2023
At Holly Health, we are transforming the way individuals approach mental and physical well-being. Founded in 2020, we’ve developed an AI-powered digital health coach that empowers users to turn their health intentions into clear, actionable steps. Our personalized, compassionate service is designed to fit seamlessly into everyday life, supporting long-term, sustainable health changes. Using proprietary AI systems, Holly Health mimics the guidance of a human health coach, offering support in areas such as weight management, stress reduction, wellness, and sleep. We are proud to be ranked among the top 3 health apps by ORCHA, the world’s leading health app evaluation body, with a score of 89%. Since our international launch in 2021, Holly Health has been on a mission to improve the lives of 5 million people by 2025. We are rolling out partnerships with over 100 primary care practices in the UK, helping healthcare professionals support patients with preventative health measures and ongoing well-being. At Holly Health, we believe that health is not a destination but a journey. By offering tailored, science-backed coaching, we make it easier for people to prioritize their well-being every day. Join us as we revolutionize digital health coaching for the modern world.
Holly Health
Seed Round in 2023
Holly Health is a digital health coaching application that assists individuals in transforming their health intentions into actionable daily habits for improved mental and physical wellbeing. Utilizing proprietary AI systems, the service mimics the support of a human health coach, offering personalized guidance to users. The application features tools such as habit reminders, tailored health content, and progress tracking, all aimed at helping users establish and maintain healthier routines. Recognized as one of the top health apps for weight management, stress reduction, wellness, and sleep, Holly Health achieved a notable evaluation score of 89% from ORCHA, a leading health app assessment organization. Launched internationally in Summer 2021, the company aims to support five million individuals by 2025 and is actively partnering with primary care practices in the UK, having established over 100 collaborations to date.
Beta Bugs
Venture Round in 2023
Beta Bugs is an insect genetics company focused on developing high-performance breeds of Black Soldier Fly for insect farmers. The company's primary mission is to enhance the productivity of the insect protein sector, making it competitive with traditional feed ingredients such as fishmeal and soymeal. To achieve this, Beta Bugs operates a breeding program called HiPer-Fly® and runs an egg production site known as The Multiplier®, supplying its breeds to both UK and international markets. By leveraging biotechnology and breeding techniques, Beta Bugs aims to establish a sustainable protein source that converts food waste into high-quality protein for use in livestock, aquaculture, and pet feed, thereby providing an alternative to conventional feed sources. The company is headquartered at the Easter Bush Campus, collaborating with the Roslin Institute, a leader in animal genetics.
Brainomix
Grant in 2023
Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.
Carbogenics
Seed Round in 2023
Carbogenics Ltd is a company based in Edinburgh, United Kingdom, specializing in the development and production of sustainable fertilizers and bio-additives. Established in 2016, Carbogenics has created an innovative process that transforms disposable coffee cups and other non-recyclable paper waste into a carbon-rich material, known as CreChar. This product serves as a carbon additive that enhances biogas production in anaerobic digestion and improves plant growth, ultimately benefiting farmers by increasing crop yields and profitability. In addition to its product offerings, Carbogenics also provides consultancy and analytical services to operators in the anaerobic digestion and wastewater treatment sectors, addressing customer inquiries through various communication channels.
Pensana
Grant in 2023
Pensana is a mineral exploration and development company focused on the supply chain for rare earth metals essential for electric vehicles, wind turbines, and other strategic industries. The company operates primarily in Angola and the UK, with key projects including the Longonjo and Coola Exploration sites. Pensana aims to provide traceable rare earth products while committing to producing the lowest embedded carbon in the market. By leveraging its resources and expertise, the company is positioned to meet the growing demand for sustainable and responsibly sourced rare earth materials.
Stablepharma
Grant in 2023
Stablepharma Ltd specializes in developing innovative processes for vaccine stabilization, focusing on its technology platform, StablevaX™, which transforms existing approved vaccines, therapeutics, and diagnostics into thermostable products that do not require refrigeration. This advancement addresses the global challenges associated with cold chain logistics, allowing for efficient and waste-free vaccine delivery. The company has identified up to 60 vaccine candidates suitable for its technology and collaborates with global vaccine manufacturers, academic institutions, and non-governmental organizations to enhance its pipeline of thermostable products. Founded in 2012 and based in Bath, United Kingdom, Stablepharma aims to reduce costs and carbon emissions while expanding access to vaccines for both children and adults.
Kubos Semiconductors
Grant in 2023
Kubos Semiconductors Ltd, established in 2017 and based in Cambridge, United Kingdom, specializes in the development and commercialization of cubic gallium nitride (GaN) technology for the LED manufacturing industry. The company focuses on producing high-efficiency, low-cost semiconductors that enable the creation of green light-emitting diode stacks. By utilizing exclusive licenses for cubic growth and silicon substrates, Kubos Semiconductors aims to enhance energy savings for its clients while reducing production costs. Its innovative approach positions the company as a key player in advancing LED technology through the application of its intellectual property.
Laytrix
Grant in 2023
Laytrix Limited specializes in the development of equipment for laying and removing subsea pipelines, serving the offshore industry. Founded in 2017 and headquartered in Darlington, United Kingdom, the company provides a range of solutions tailored to client needs, including design and build, rental, or licensing options. Laytrix's product offerings encompass various modes of operation, such as pipelay mode, carbon capture and storage pipelines, flex lay mode, and pipeline recovery, along with capabilities for decommissioning pipe bundles and cargo handling. Their innovative systems enable clients to efficiently install, utilize, and demobilize equipment, thereby reducing costs and minimizing risks across the oil and gas, renewables, and marine sectors.
Damibu Ltd
Grant in 2023
Damibu Ltd is a technology company specialising in innovative digital solutions, particularly for healthcare and public sector organisations. They focus on creating platforms that simplify content management and distribution, enhancing communication efficiency. Notably, their product Damibu Feeds aids NHS groups in the UK by automating content sharing among GP surgeries, saving time and resources. Their approach emphasises user-friendly designs and interoperability, ensuring seamless integration with existing systems. Damibu's commitment to improving digital health communication is evident in their solutions, which aim to streamline processes, ensure content accuracy, and enhance patient engagement through reliable and accessible information dissemination.
Kalium Health
Grant in 2023
Kalium Health Ltd is a company focused on improving kidney care through innovative medical technology. Based in Cambridge, United Kingdom, it designs and manufactures a finger-prick blood test specifically for measuring blood potassium concentration. This test aims to facilitate early treatment for patients, reducing the complications and costs associated with traditional testing methods. By leveraging advanced electrolyte sensing technology, Kalium Health provides patients with accurate, real-time data essential for managing cardiorenal diseases. The company’s first product addresses a significant risk in kidney disease, a condition that imposes substantial financial burdens on healthcare systems. With a clear regulatory pathway and a targeted market strategy, Kalium Health is poised to transform patient care and enhance outcomes for millions affected by kidney disease.
Infleqtion
Grant in 2023
Infleqtion specializes in quantum technology, providing high-value information processing and solutions that enhance global communication security and efficiency. The company, with offices in the United States, United Kingdom, and Australia, leverages over 17 years of foundational research from ColdQuanta to deliver software-configured, quantum-enabled products that operate at the Edge. These products focus on critical applications such as positioning, navigation, timing, and resilient energy distribution, while also facilitating accelerated quantum computing. Infleqtion serves a diverse clientele, including commercial organizations and government entities, helping them to harness the power of quantum technology for innovation and development.
CGT Catapult
Grant in 2023
The Cell and Gene Therapy Catapult is a UK-based center dedicated to fostering innovation in the cell and gene therapy sector. Supported by Innovate UK, its primary objective is to accelerate the development of commercially viable therapies by assisting organizations in translating early-stage research into market-ready products. The Catapult employs over 120 experts in cell and gene therapy and features advanced laboratories for development and viral vector research. Additionally, it is in the process of establishing a £55 million large-scale Good Manufacturing Practice (GMP) manufacturing center to facilitate the market introduction of cell and gene therapies both in the UK and internationally. By offering expertise in clinical trials, process development, manufacturing, regulatory affairs, health economics, and market access, the Catapult aims to help research organizations achieve full-scale commercialization of their therapies.
Autolomous
Grant in 2023
Autolomous Ltd, founded in 2019 and based in Mayfair, United Kingdom, specializes in developing software solutions for manufacturers of cell and gene therapies. Its flagship platform, autoloMATE®, is a cloud-native system that provides comprehensive support for Advanced Therapies and Vector manufacturing processes. The software facilitates the scheduling of patient cell collections, the transport of these cells to production sites, and the tracking of manufacturing processes to ensure compliance with regulatory standards. It also supports the legal release and timely delivery of patient-specific medicines. The highly configurable platform allows clients to customize workflows and integrates seamlessly with existing systems. Autolomous emphasizes data security by utilizing blockchain technology to maintain the integrity of manufacturing data. The company adheres to strict regulatory guidelines and has achieved several ISO certifications, reflecting its commitment to quality management and environmental standards.
Bridgit Care
Grant in 2023
They care for carers all over the UK with whatever complex needs they may have. They help carers to find carer support resources within their local communities, as well as nationally or with their organisation. All of their solutions deliver to UK addresses, so there is no need for carers and their loved ones to leave the comfort of their own homes to access carer support.
Equality Group
Grant in 2023
Equality Group is a consulting organization based in London, United Kingdom, founded in 2018. It specializes in diversifying businesses within the finance, technology, and social impact sectors. The firm offers a range of services, including executive search, strategic consultancy, and inclusion education. Additionally, it has developed Honordex, a data platform that benchmarks and ranks companies based on their equity, diversity, and inclusion (EDI) performance. Through its comprehensive approach, Equality Group aims to foster inclusive environments and enhance organizational effectiveness.
Orthonika
Grant in 2023
Orthonika Limited, established in 2014 and based in London, United Kingdom, specializes in the development and manufacturing of MenisciKnit, an anatomical meniscus replacement designed to address severe meniscus injuries. These injuries can significantly impair mobility and lead to complications such as osteoarthritis and the need for knee arthroplasty. Current treatment options, including partial meniscectomy and allograft transplantation, often fall short, leaving a significant unmet need in the market. MenisciKnit employs a unique fiber-reinforced material structure that closely mimics the natural meniscus, aiming to restore proper knee biomechanics. This innovative approach not only provides a solution for those with severe meniscus damage but also supports patients in resuming active lifestyles and offers a comprehensive alternative to traditional knee-related treatments.
i2 media research
Grant in 2023
i2 media research limited is a small interdisciplinary team of experts in how humans and technology can work together – for the benefit of consumers and business. We're the expert consumer insight and user experience research and strategy consultancy based at Goldsmiths University of London, delivering rigorous research and innovation to business. Founded in 2002 as a spin off from Psychology at Goldsmiths, University of London, we are now in our 16th successful year of business. Fully self-funded through commissioned projects and through collaborative research and development projects, i2 media has successfully completed more than 200 commissions, focused on both sides of (and across) the digital divide: from late adopters, to people with very specific access and usability needs, to the earliest adopters of the latest technology and service innovations.
InsideOut
Grant in 2023
InsideOut is a London-based company that focuses on mental health care and well-being support. It has developed a therapy platform aimed at reducing social stigma surrounding mental health and fostering open conversations about the subject. The platform provides continuous therapy support through an online application, which employs an intelligent matching system to connect users with suitable therapists. This approach enables individuals to maintain positive mental well-being by accessing tailored therapeutic resources and support.
SyncVR Medical
Grant in 2023
SyncVR Medical is dedicated to enhancing healthcare through virtual and augmented reality (VR/AR) solutions. As the largest XR platform for healthcare in Europe and the UK, the company serves over 125 healthcare institutions across several countries, including the Netherlands, Germany, Denmark, Sweden, Belgium, the UK, and France. SyncVR Medical's platform offers a range of applications designed to support patient care, alleviate pain and anxiety, and improve treatment outcomes based on scientific research. Additionally, more than 25 third-party developers contribute to the platform, providing access to a broader customer base in the healthcare sector. SyncVR Medical aims to establish itself as the leading XR platform in the top five European healthcare markets by 2025.
Oxford Dynamics
Grant in 2023
Oxford Dynamics develops robotics & AI solutions for space, security & defence sectors. AVIS (A Very Intelligent System) is OD's flagship generative AI platform for the processing of complex multimodal data. Designed to augment human data analysts, AVIS 'force multiples' their throughput; freeing humans to concentrate on high-level decision-making as opposed to lower-level data sifting and comparison. AVIS is in use by a number of UK government agencies via a Framework Lite Agreement. Oxford Dynamics robotics work includes its STRIDER platform, an AI-enabled tracked robot developed to assist with response to Chemical, Biological, Radiological and Nuclear (CBRN) events. Oxford Dynamics is self-funded via a mix of founders cash, grant and contract wins.
Cineon Immersive Training
Grant in 2023
Cineon Immersive Training, based in Exeter, England, specializes in providing a variety of training services, including virtual, behavioral, and immersive training. The company offers eye tracking services that assess a person's attention and concentration, which can indicate their mental, emotional, and cognitive health. In addition to eye tracking, Cineon delivers instructor-led training, e-learning, and virtual reality training solutions tailored for high-risk environments. Their comprehensive approach aims to enhance users' skills and improve overall performance through innovative training methodologies.
Outfield
Grant in 2023
Outfield is an agritech company focused on transforming orchard management through its precision farming platform. By utilizing unmanned drones and advanced image recognition technology, Outfield collects and analyzes data to deliver actionable insights on key aspects such as fruit counts, blossom mapping, crop load management, and yield forecasting. This innovative approach significantly improves the accuracy of yield estimates, reducing common errors from 20% to less than 10%, thereby enhancing productivity and profitability for growers. The platform processes drone-captured images and returns detailed maps and insights to users within 24 hours, allowing for efficient decision-making. Currently, the service is being tested by growers in the UK, New Zealand, and South Africa, who have praised its flexibility and speed. Outfield aims to scale its operations, expand its offerings, and enter new market segments as it addresses the growing demand for sustainable and efficient fruit farming solutions.
Flybox®
Grant in 2023
Flybox® is an Insect Waste Management (IWM) company delivering innovative insect bioconversion technology and expert support to revolutionise waste management. Flybox® provides tailored IWM solutions for established waste and food businesses, alongside a streamlined breeding and monetisation service that simplifies startup and scaling for new operators. Its modular IWM systems integrate seamlessly with existing waste infrastructure, allowing businesses to transform organic waste streams and byproducts into valuable proteins and fertilisers. With patented technology and a steadfast commitment to circular economy principles, Flybox® is advancing global efforts to reduce landfill dependency, minimise reliance on deforestation-linked soy, and enhance food security. Headquartered in the UK and active internationally, Flybox® is a leader in sustainable waste solutions, driving positive change across agriculture, waste management, and environmental resilience.
RoboK
Grant in 2023
RoboK is a computer vision startup based in Cambridge, United Kingdom, founded in 2017. The company specializes in designing and developing simultaneous localization and mapping (SLAM) algorithms and advanced 3D sensing technologies tailored for automotive and industrial applications, including autonomous driving and machine automation. RoboK focuses on enhancing safety and performance in industrial workplaces through innovative, privacy-preserving technology that optimizes the capabilities of existing CCTV systems. By transforming visual data from large-scale transport and logistics infrastructures into actionable insights, RoboK collaborates with major operators in critical sectors to deliver enhanced object detection, classification, and tracking. The company aims to maximize the value of visual data, turning passive surveillance systems into proactive tools for efficiency and safety.
Vitarka Therapeutics
Grant in 2023
Vitarka Therapeutics develops medical technology and solutions for various types of cancer. It is based in London, United Kingdom.
Nanovery
Grant in 2023
Nanovery Limited, founded in 2018 and based in London, United Kingdom, specializes in developing nanorobots aimed at detecting cancer mutations. The company's innovative platform utilizes artificial intelligence to facilitate the rapid and ultra-sensitive identification of challenging biomarkers in blood samples. These nanorobots can capture circulating tumor DNA and emit a fluorescent signal, enabling healthcare professionals to conduct point-of-care tests. By facilitating early cancer detection, Nanovery aims to enhance patient outcomes and increase survival rates. The organization is supported by a team of experts in nanotechnology, medicinal chemistry, and artificial intelligence, along with backing from leading academics, clinicians, and industry leaders.
QV Bioelectronics
Grant in 2023
QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.
CLUBZERØ
Grant in 2023
CLUBZERØ addresses the pressing issue of packaging waste through its innovative AI-powered zero waste packaging system, offering a scalable and cost-effective alternative to single-use packaging. The company provides a comprehensive service that includes packaging, drop-off points, and logistics, resulting in costs that can be up to 30% lower than traditional single-use options. CLUBZERØ's model stands out by achieving true zero waste, avoiding the contamination and greenhouse gas emissions associated with compostable packaging. By transitioning to CLUBZERØ, brands can potentially reduce CO2 emissions by up to 93%. The system, which uses advanced AI for interoperability, has been successfully implemented in the UK and U.S., fulfilling over 1.3 million orders and preventing 2.6 million single-use items from reaching landfills. The company has partnered with major brands such as Starbucks, McDonald’s, and Coca-Cola, earning accolades from organizations like the Ellen MacArthur Foundation. CLUBZERØ's goal is to transform the returnable packaging sector, enhancing scalability and adaptability while providing a sustainable solution for the food and beverage industry.
Productive Machines
Grant in 2023
Productive Machines that enable machining companies to be faster to the best part, first time, in an automated way. Unlike competitors who are stuck in a labour intensive iterative cycle to produce parts. Productive Machines have a digital twin of the physics, mechanics, dynamics, distortion and vibration of the machining process for metal cutting, enabling the company to test millions of parameters in simulation to enhance CAM and Gcode to improve productivity and part quality. Productive Machines is a spin out from the UK Advanced Manufacturing Research Centre (AMRC)
Multus
Grant in 2023
Multus is a London-based company established in 2019 that specializes in providing affordable and efficient growth media for the cultivated meat industry. By employing a machine learning approach, Multus develops entirely animal-free growth media tailored specifically for animal cells, helping cultivated meat companies scale their production while maintaining high performance. The company focuses on optimizing growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the environmental drawbacks associated with traditional animal serum-based media. This innovative solution supports the growth of diverse animal cell types and tissues, enabling clients to produce sustainable meat products while minimizing the environmental and economic impacts of conventional meat production.
Brainspark Games
Grant in 2023
Brainspark Games is an Edtech Gaming studio, building free, culturally inclusive, AI-powered, Augmented Reality educational mobile games, aligned with the UK national curriculum.
Brainspark Games
Grant in 2023
Brainspark Games is an Edtech Gaming studio, building free, culturally inclusive, AI-powered, Augmented Reality educational mobile games, aligned with the UK national curriculum.
Healthera
Debt Financing in 2022
Healthera operates a comprehensive healthcare marketplace in the UK, connecting patients with medicines, healthcare services, and products through a vast digital platform that includes both national pharmacy chains and independent providers. The company's technology facilitates quicker medicine delivery and personalized medical care tailored to individual needs. By reinventing the pharmacy operating model, Healthera enhances patient communication, encourages cross-sales, and fosters customer loyalty. The company is dedicated to digitizing and automating primary care processes, which improves prescribing efficiency and the overall patient experience while minimizing waste for the NHS. Partnering with over 1,000 pharmacies and clinical commissioning groups, Healthera reaches more than 20 million individuals. Its technology is accredited by NHS Digital, positioning Healthera as one of the fastest-growing digital health firms in Europe. Headquartered in Cambridge, the company boasts a diverse international team committed to improving healthcare delivery through human-centered technology.
WeWALK
Grant in 2022
WeWALK Limited is a company based in London, United Kingdom, that develops innovative mobility tools for visually impaired individuals. Founded in 2017, WeWALK has created a smart cane equipped with advanced technology, including an ultrasonic sensor that detects obstacles above chest level and vibrates to alert users of nearby objects. This smart cane is enhanced by the WeWalk mobile application, which facilitates outdoor navigation, wayfinding, and public transportation integration. The company aims to empower visually impaired individuals by promoting independence and safety in their daily lives, thereby fostering social inclusion and transforming mobility experiences through the use of artificial intelligence and modern technology.
Vann
Grant in 2022
Vann is a platform for people affected by cancer aiming to help millions of people globally and revolutionize cancer research and care. Vann has been backed by the Oxford University Innovation, Innovate UK, OxLEP European Regional Development Fund, and UK angel investors and is based in the UK.
iethico
Grant in 2022
iEthico is a company focused on resolving drug supply and shortage issues through a digital supply chain platform. This platform streamlines the sourcing of medicines by providing automated, cloud-based services that track data and generate essential insights. It alerts users to potential shortages and connects pharmacists with reliable suppliers, thereby empowering them to manage their inventory effectively. The service features an MHRA-approved automated regulatory process that minimizes paperwork, saving time for pharmacies. Following successful market testing, iEthico's solution is currently being rolled out to community pharmacies and NHS Trusts across the UK, aiming to enhance the efficiency of medicine distribution and reduce costs for healthcare providers.
OutThink
Seed Round in 2022
OutThink is a London-based cybersecurity start-up that specializes in a human risk management platform designed to enhance employee engagement and foster a risk-aware culture within organizations. Recognized for its innovative approach by industry leaders, the company offers a SaaS solution that identifies and mitigates risky behaviors among the workforce. By quantifying human risk, OutThink's platform enables organizations to tailor awareness training based on employee behaviors and attitudes, thereby improving cybersecurity engagement and productivity. This targeted approach not only reduces employee risk but also assists clients in complying with regulatory standards, addressing the increasing demand for a well-trained workforce in the face of rising cyber threats.
LabGenius
Grant in 2022
LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.
Acurable
Grant in 2022
Acurable Limited is a MedTech start-up based in London that specializes in the design and commercialization of a wearable sensor-based health care device aimed at diagnosing and managing respiratory conditions in a non-invasive manner. The company's flagship product, AcuPebble, allows for the diagnosis of sleep apnea and the monitoring of various respiratory and cardiac conditions through advanced algorithms that analyze acoustic signals. This technology, which emerged from a decade of research at Imperial College London, provides more accurate readings than existing solutions, significantly reducing the risk of misdiagnosis. AcuPebble is designed for home use, requiring no specialist training, which helps lower healthcare costs. Acurable's mission is to gain a comprehensive understanding of human biosignals to ensure that treatable conditions do not result in preventable deaths.
Adamo Foods
Grant in 2022
Adamo Foods is a UK-based food technology company focused on developing plant-based whole-cut meats through innovative fermentation techniques and mycelium. The company aims to produce sustainable alternatives to traditional meat products, utilizing precision fermentation to create functional meat proteins. By harnessing fungal mycelium, Adamo Foods offers consumers an efficient, sustainable, and ethical way to enjoy meat-like experiences without sacrificing taste or quality.
Aegiq
Grant in 2022
Aegiq Ltd. is a company based in Sheffield, United Kingdom, specializing in semiconductor-based quantum photonic chips. Established in 2019, it focuses on developing a universal quantum computing platform that integrates photonic quantum computing and networking technologies. Aegiq's solutions cater to a variety of industries, including defense, aerospace, cybersecurity, and artificial intelligence, addressing complex computational challenges with an emphasis on speed, compactness, and modularity. The company's innovative hybrid integrated photonics approach aims to facilitate large-scale quantum computing with the capacity for multi-million qubit operations, ultimately contributing to advancements in quantum cybersecurity and networking.
Stemnovate
Grant in 2022
Stemnovate Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2016. It specializes in providing innovative tools and technologies for drug screening and safety testing. Its offerings include induced pluripotent stem cells, human and multispecies primary cells, and a comprehensive cell culture and analysis package. The company utilizes advanced devices such as micro physiological systems and microfluidic designs to enhance drug discovery. One of its notable projects, "Liver on chip," focuses on liver toxicity testing and incorporates techniques like cellular reprogramming and organ-on-chip technology. Stemnovate also offers services in cell reprogramming, differentiation, and application development, catering to a diverse clientele that includes pharmacists, contract research organizations, small to medium enterprises, and academic institutions.
Paragraf
Grant in 2022
Paragraf Ltd. is a UK-based company specializing in the development of graphene technology and the production of two-dimensional materials. Established in 2015, Paragraf focuses on creating graphene-based electronic devices, including magnetic sensors and biosensors, that are designed to enhance technological performance in various sectors such as electronics, energy, research, automation, and healthcare. The company employs contamination-free technology to ensure the production of high-purity graphene products that meet commercial quality standards. Paragraf's innovations aim to optimize process control, improve quality assurance, and facilitate monitoring of environmental and health conditions, thereby contributing to advancements in green energy generation and other critical applications.
Better Nature
Grant in 2022
Better Nature Ltd. specializes in the production of packaged organic food products, focusing primarily on plant-based protein offerings. The company’s product range includes various forms of tempeh, such as tempeh mince, tempeh rashers, smoked tempeh, and lupin tempeh, all designed to support a vegan diet. Tempeh, a key ingredient in their products, is made by fermenting cooked soybeans, resulting in a nutrient-dense block that is rich in protein, prebiotics, and fiber, while also being gluten-free. Established in 2018 and headquartered in Chesterfield, United Kingdom, Better Nature distributes its products through an online platform, making them accessible to a wider audience seeking healthy and sustainable food options.
Biotangents
Debt Financing in 2022
Biotangents was founded upon their Leapfrog Assembly™ platform technology for building complex genetic constructs from multiple DNA parts. This was developed through a SMART: Scotland award from Scottish Enterprise and was exe0mplified through the generation of their terpenoid biosynthesis strains. During that successful first year they also developed their DNA randomisation technology, Short Sequence Randomisation™. In 2016, having formulated a concept for a modular cell-free nucleic acid detection technology, Moduleic Sensing™, and with support from SynbiCITE, they commenced development of their first diagnostic test, a highly specific and sensitive solution for pen-side diagnosis of infectious diseases in livestock.
Earth Rover
Grant in 2022
Earth Rover Limited is a company based in Newport, United Kingdom, that specializes in developing robotic agriculture systems aimed at enhancing farming practices. Founded in 2017, the company creates autonomous farming robots designed to improve precision farming through applications such as scouting, weeding, and selective harvesting. These robots utilize technology originally developed for the ExoMars Rover, modified to support precision tools and to work in conjunction with an intelligent data platform. This innovative approach enables farmers to transition from traditional farming methods to more autonomous and efficient agricultural practices, promoting the production of fresh and chemical-free products.
Stok.ly
Grant in 2022
Stokly Ltd is a UK-based company that specializes in designing and developing multi-channel retail software solutions for small to medium-sized retailers. Founded in 2015 and headquartered in Hereford, the company offers a cloud-based platform that enables retailers to manage their businesses across various e-commerce channels, including their own websites, Facebook, and eBay. Stokly's software features inventory management, ePOS capabilities, and seamless integration with multiple online retail platforms. By providing a user-friendly interface accessible from any device, Stokly allows retailers to oversee their operations from a single dashboard, enhancing efficiency and facilitating growth without upfront fees or long-term contracts.
Puraffinity
Grant in 2022
Puraffinity Ltd, founded in 2015 and based in London, specializes in innovative water treatment and purification solutions. The company, which was previously known as Customem Ltd before rebranding in July 2019, has developed a sustainable bio-based adsorbent material designed to effectively remove challenging pollutants from contaminated water and wastewater. Utilizing advanced supramolecular chemistry, Puraffinity's technology allows for the selective capture of micro-pollutants, including pesticides, pharmaceuticals, and hazardous chemicals such as per- and polyfluoroalkyl substances. This capability enables clients to comply with stringent wastewater regulations while contributing to the protection of local ecosystems. Puraffinity is committed to addressing pressing water quality challenges through environmentally sustainable practices.
Outfield
Grant in 2022
Outfield is an agritech company focused on transforming orchard management through its precision farming platform. By utilizing unmanned drones and advanced image recognition technology, Outfield collects and analyzes data to deliver actionable insights on key aspects such as fruit counts, blossom mapping, crop load management, and yield forecasting. This innovative approach significantly improves the accuracy of yield estimates, reducing common errors from 20% to less than 10%, thereby enhancing productivity and profitability for growers. The platform processes drone-captured images and returns detailed maps and insights to users within 24 hours, allowing for efficient decision-making. Currently, the service is being tested by growers in the UK, New Zealand, and South Africa, who have praised its flexibility and speed. Outfield aims to scale its operations, expand its offerings, and enter new market segments as it addresses the growing demand for sustainable and efficient fruit farming solutions.
Anya
Debt Financing in 2022
For expectant & new parents, Anya is the best tool to support you through your early parenthood & breastfeeding journey. Anya is here to support you with credible & expert guidance every step of the way, using unique LatchAid™ 3D interactive breastfeeding animations, the Anya virtual supporter answering your questions 24/7, real-life experts ready to help, & close-knit communities where you can connect with other parents. Whether you have questions about pregnancy, birth, latching, combination feeding, pumping, cluster feeding, milk supply, reflux, sleep, nappies, going back to work or more, Anya offers peer-to-peer support & professional assistance. Giving you confidence to be the parent you want to be, so you don’t feel exhausted, frustrated or in pain. Anya is an easy-to-use app for parenting & breastfeeding support, including: LatchAid™ 3D breastfeeding tool: * Interactive animations to help you learn breastfeeding skills visually. * Camera responds to your touch & shows you how to position your baby at the breast, using your desired angles & X-ray mode to see inside the baby’s mouth. * Demonstrating different breastfeeding positions, accompanied by audio & subtitles. * Personalise breast sizes & skin tones to represent you & your baby. Anya AI virtual supporter: support anytime, anywhere: * Providing parents with personalised support & companionship, 24/7, worldwide. * Answers all your questions regarding infant feeding, baby care, pregnancy, & parental health. * Our knowledge base is constantly evolving based on hundreds of questions from parents like you worldwide. * Access 1-1 support from our real-life experts on anything about mother & baby wellbeing, or parental health to get credible, evidence-based answers. Peer support communities: * It takes a village to raise a child. Connect with other parents to share knowledge & experience, to create lasting friendships & access help through in-app virtual chat groups. Parenting & breastfeeding support: * Access the knowledge base of top experts with internationally-recognised qualifications. * Tailored insight page to your baby's age & stage. * Explore articles, videos & FAQs related to your current stage 24/7. * Join in with our in-app events or watch them back to suit you. Interactive expert webinars: * Connect with qualified infant feeding, baby care, & parental health experts in weekly webinars & drop-in Q&A sessions. * Get professional advice in a supportive environment, all from the comfort of your own home. Why download Anya? * Anya is the only breastfeeding & early parenthood support app powered by empathy & innovation. * Downloaded & trusted by 1000s of parents around the world. * You can learn to breastfeed confidently with our help. Solves a problem 90% of new mothers face, due to pain, lack of support & faltering confidence with breastfeeding. * Recommended by the NHS in the UK, so you know it’s high quality. * An innovative & complementary solution to traditional breastfeeding support that offers AI virtual supporter, 1-to-1 specialist support, & a peer community to empower parents to give their child the best start in life. * We build the confidence of mothers to achieve their infant feeding goals with animations, peer community, 24/7 specialist support & personalised AI companion. As soon as you become a parent, you have questions, lots of them! Anya and LatchAid™ were developed by specialists who work with parents every day to help them reach their parenting & breastfeeding goals. Many mothers of newborn babies give up breastfeeding less than three months after birth, due to physical pain, frustration & anxiety. We are here to help support you with empathy & companionship and to answer all of your 3am worries. We believe that every parent deserves the support & empowerment to give their child the best start in life. Together we nurture.
Paranimo
Venture Round in 2022
Paranimo is focused on enhancing workplace mental health by providing accessible and effective support solutions. The company employs advanced matching intelligence within its software-as-a-service (SaaS) and consulting offerings, aimed at helping HR managers improve employee well-being. By connecting clients with therapists across the United Kingdom, Paranimo's technology enables therapists to evaluate and rank mental health conditions they can address, thereby creating a percentage match with potential clients. This approach facilitates convenient access to therapy sessions, promoting increased mental health awareness and support in the workplace.
Xampla
Grant in 2022
Xampla Ltd is a cleantech company based in Cambridge, United Kingdom, that specializes in developing plant protein-based materials as sustainable alternatives to traditional plastics and microplastics. Founded in 2018, Xampla produces a variety of products, including microcapsules, films, coatings, and beads, which are designed for use in sectors such as food, cosmetics, household products, animal feed, packaging, and medical applications. All materials are biodegradable and biocompatible, made without synthetic ingredients, allowing clients to create environmentally friendly products that minimize pollution.
ev.energy
Grant in 2022
Ev.energy is a London-based smart charging software platform for electric vehicles, founded in 2018. The company specializes in energy intelligence software that connects wirelessly to various electric vehicles and Level 2 chargers. It intelligently manages the charging process in alignment with utility and network signals, aiming to make charging both cleaner and more affordable for users. Through a mobile application, Ev.energy engages customers and offers rewards, enabling them to charge their electric vehicles at home while effectively reducing both costs and carbon emissions.
Drone Ag
Grant in 2022
We make farming more productive through practical, hassle-free drone automation and Ai software. We are a UK based team of farmers, agronomists, drone pilots and software engineers that provide drone training courses and easy to use software solutions. We have been using drone systems on our own 6000 acre farm for years and we base all our solutions on what we have learnt in that real-world farm environment. We’re still learning, and as we learn we pass that knowledge onto our clients through training and use it to build unique software, making us the best option to stay at the forefront of practical drone use in precision agriculture.
Sixfold Bioscience
Grant in 2021
Sixfold Bioscience Inc. focuses on developing innovative drug delivery techniques aimed at treating cancer patients. Founded in 2018 and headquartered in London, the company specializes in programmable oligonucleotide delivery systems that target RNA specifically to diseased cells. This approach enhances the precision and effectiveness of cancer treatments, positioning Sixfold Bioscience as a significant player in the biotechnology sector.
SeeQC
Grant in 2021
SeeQC, Inc. is a developer of digital quantum computing platforms aimed at global businesses, with a focus on creating commercially viable application-specific quantum computing systems. Founded in 2018 and headquartered in Elmsford, New York, the company specializes in the design, testing, and manufacturing of quantum-ready superconductors. It integrates classical and quantum technologies to tackle common challenges in efficiency, stability, and cost associated with quantum computing. SeeQC's offerings include superconducting qubit chips and proprietary Single Flux Quantum (SFQ) technology, enabling high-performance classical co-processors and application-specific integrated circuits (ASICs). The company's approach combines digital readout and control technology with a unique chip-scale architecture to deliver scalable and cost-effective quantum computing solutions suitable for sectors such as machine learning, logistics optimization, quantum chemistry, pharmaceuticals, and fintech. Additionally, SeeQC operates facilities in London, United Kingdom, and Naples, Italy, enhancing its capacity to serve clients across the United States and Europe.
SETsquared Partnership
Grant in 2021
SETsquared is a collaborative partnership established in 2001, based in Southampton, United Kingdom, involving the Universities of Bath, Bristol, Exeter, Southampton, and Surrey. This initiative focuses on fostering the growth of high-tech startups by providing business incubation services, which include mentoring, access to investors and experts, and tailored training programs. In addition to supporting enterprise activities and spin-outs, SETsquared engages with industry through research collaboration and consultancy, facilitating the development of new business opportunities and enhancing the success of its partners in the technology sector.
Addionics
Grant in 2021
Addionics is a London-based company, founded in 2017, that specializes in the design and development of next-generation rechargeable batteries, particularly for electric vehicles. The company utilizes an innovative 3D battery architecture to create batteries with improved energy density, reduced charging times, and enhanced safety. By redesigning the internal structure of batteries at a microscopic level, Addionics aims to minimize internal resistance and increase mechanical longevity, which significantly enhances performance across various battery chemistries. The company is focused on scaling its proprietary technology to revolutionize energy storage solutions and positively impact environmental sustainability, catering to the growing demand from battery manufacturers and automakers for advanced energy storage systems.
Bonnet
Grant in 2021
Bonnet Ltd. is a London-based company founded in 2019 that specializes in a charging-as-a-service platform for electric vehicle drivers. The company addresses the challenges faced by drivers who must register separately for multiple public charging networks by offering a single app that enables access to any public charger. This streamlined service caters to both individual drivers and businesses, simplifying the charging process and enhancing the overall user experience for electric vehicle owners.
Anaphite
Seed Round in 2021
Anaphite Limited, established in 2016 and located in Bristol, United Kingdom, focuses on the development of graphene-based nanomaterials. The company specializes in creating graphene-enhanced cathodes designed for high-power, high-energy, and cost-effective lithium-ion batteries. Anaphite's innovative approach involves integrating graphene into composite materials through a scalable and economical process. This technology results in advanced properties that make their nanomaterials suitable for a variety of applications, including energy storage, air purification, and thermal management. By prioritizing affordability and versatility, Anaphite aims to make significant contributions to the commercialization of these technologies.
Levistor
Grant in 2021
Levistor is a British company focused on advancing energy storage solutions specifically for electric vehicles. The company is developing a cost-effective and durable technology that facilitates ultra-rapid charging for EVs. This innovative approach aims to enhance the efficiency of battery performance while minimizing environmental impact by replacing harmful battery chemicals with more conventional materials like steel and copper, which have a lower carbon footprint. Levistor's technology is designed to meet the growing demand for electric transport by ensuring that stored energy can be quickly delivered to vehicles upon arrival.
Paranimo
Grant in 2021
Paranimo is focused on enhancing workplace mental health by providing accessible and effective support solutions. The company employs advanced matching intelligence within its software-as-a-service (SaaS) and consulting offerings, aimed at helping HR managers improve employee well-being. By connecting clients with therapists across the United Kingdom, Paranimo's technology enables therapists to evaluate and rank mental health conditions they can address, thereby creating a percentage match with potential clients. This approach facilitates convenient access to therapy sessions, promoting increased mental health awareness and support in the workplace.
CCm Technologies
Grant in 2021
CCm Technologies is an environmental technology company established in 2011 and based in Begbroke, England. The company specializes in resource optimization by focusing on the efficient use of industrially segmented carbon dioxide (CO2). Through its patented technology, CCm Technologies offers a solution that permanently and cost-effectively removes CO2 from the environment, generating energy while reducing industrial waste. The process also produces significant amounts of usable heat during CO2 capture. This enables clients, particularly those operating oil sands recovery plants, to utilize captured CO2 in the creation of various commercially valuable products.
Rinri Therapeutics
Grant in 2021
Rinri Therapeutics Limited is a biotechnology company based in Sheffield, United Kingdom, focused on developing regenerative stem cell-based therapies to treat hearing loss. Founded in 2018, the company specializes in advanced stem cell technology that aims to repair damaged or dead sensory cells in the inner ear, specifically targeting sensorineural hearing loss. By restoring the cytoarchitecture of the inner ear, Rinri Therapeutics seeks to enable medical professionals to effectively restore hearing for affected patients.
Arecor
Grant in 2021
Arecor Limited, based in Cambridge, United Kingdom, specializes in stabilization technology solutions for pharmaceutical and biotech companies. The company collaborates with these firms to enhance the commercial viability and usability of various proteins across multiple applications, including vaccines and therapeutic proteins. Arecor focuses on developing products for infectious diseases, diabetes, oncology, and autoimmune disorders, and aims to create high-concentration therapies that patients can self-administer at home. Notable projects include reformulating antibodies such as Trastuzumab and Rituximab for improved home treatment of breast cancer and non-Hodgkin’s lymphoma, respectively. Additionally, Arecor develops stable liquid formulations for vaccines and therapies that facilitate self-administration, addressing challenges related to stability and degradation. Founded in 2006, Arecor is recognized for its innovative formulation technology platform, which underpins its proprietary product portfolio and partnerships with industry leaders to advance biopharmaceutical development.
Camallergy
Grant in 2021
Camallergy Limited, based in Cambridge, United Kingdom, is a biopharmaceutical company established in 2015 that focuses on developing and manufacturing oral immunotherapy drugs and other pharmaceutical products specifically for food allergies. The company's primary offering is a novel oral immunotherapy designed to treat peanut allergies, which aims to provide patients with "bite-proof" protection within 14 weeks of therapy. This patient-centric treatment addresses the urgent needs of millions suffering from food allergies and is rooted in clinical research conducted at Cambridge University Hospitals NHS Foundation Trust. Camallergy's unique intellectual property and treatment regimen exemplify its commitment to improving the quality of life for individuals affected by these allergies.
CN Bio
Grant in 2021
CN Bio Innovations, formerly Zyoxel Ltd, is part of the Hong Kong-based, CN Innovations Holdings Limited (CNI). CN Bio develops human organ-on-a-chip platforms for the testing and development of therapeutics for serious human diseases. The company’s leading organ-on-chip disease model is a full viral lifecycle model of hepatitis B (HBV) based on the culture of primary human hepatocytes in the company’s proprietary LiverChip platform. The HBV disease model, which is referred to as Quantum-B, is currently being deployed in drug discovery and research alliances with several leading pharmaceutical and biotech companies. Working closely with academic pioneers in the bio-engineering field, and backed by prestigious grant awards from sponsors including the United States Defence Advanced Research Projects Agency and UK Technology Strategy Board, CN Bio continues to develop next-generation organ-on-chips which will improve the quality of life for millions of people around the world by fast-tracking breakthrough therapies to market.
Potenza Technology
Grant in 2021
Potenza Technology Limited, established in 1999 and based in Warwickshire, United Kingdom, specializes in the design and development of electric and hybrid powertrain systems. As a subsidiary of FPT Industrial S.p.A., the company focuses on low and zero-emission technology, offering expertise in battery management systems, systems integration and control, and safety engineering. Potenza Technology designs and manufactures prototype and low-volume high-energy density lithium battery packs, providing clients with a comprehensive range of electronics systems tailored for automotive applications, including body systems and powertrain control.
Connected Energy
Grant in 2021
Connected Energy was established to commercialise the research and development work undertaken by their award-winning parent company Future Transport Systems (FTS). Connected Energy has developed its E-STOR stationary energy storage technology that that utilises 2nd life electric vehicle batteries. The E-STOR technology is unique in that it can utilise any EV OEM battery pack communicating with it via the OEM's proprietary CAN protocol. Connected Energy currently utilises batteries supplied by Renault, Nissan, Jaguar Land Rover and others. It has systems operating in the UK, Belgium, Germany and the Netherlands ranging from 60kW to 1.2MW and will be installing systems of 10MW+ in 2021.
ZeroAvia
Grant in 2020
ZeroAvia, Inc. is a company focused on developing zero-emission aircraft for commercial short-haul flights. Established in 2017 and headquartered in Hollister, California, with an office in Cranfield, United Kingdom, ZeroAvia specializes in hydrogen-electric propulsion systems. These systems are designed to eliminate aviation emissions while ensuring operational efficiency. The company aims to provide scalable technologies that can retrofit existing aircraft, thereby facilitating a transition to sustainable aviation. By collaborating with various stakeholders, ZeroAvia seeks to revolutionize the aviation industry through cleaner and more efficient flight options. Their powertrain utilizes a hydrogen fuel-cell system in limited-seat fixed-wing aircraft, which not only reduces emissions but also allows for the use of existing infrastructure, thus simplifying regulatory challenges and lowering both fuel and maintenance costs for aviation companies.
Visionable
Grant in 2020
Visionable Ltd is a company that specializes in designing and developing a video conferencing platform primarily for the healthcare sector. Its services include video meetings, telemedicine, medical education, and diagnostic reviews, aimed at improving patient outcomes and addressing the challenges of fragmented health systems. In addition to healthcare, Visionable also provides solutions for the education sector, offering tools for classroom training and smart board integration. The platform extends to enterprises, facilitating visual workstations and organization-wide meetings. Founded in 2015 and based in Westminster, United Kingdom, Visionable seeks to enhance collaboration by breaking down barriers between people and technology, enabling real-time communication and data sharing across various industries.
Mocean Energy
Grant in 2020
Mocean Energy, founded in 2015 and based in Edinburgh, United Kingdom, specializes in developing innovative technologies that harness wave energy to promote a transition to a zero-carbon future. The company focuses on an energy converter that enhances the generation and utilization of electricity from renewable sources. This converter drives a power take-off mechanism that transforms kinetic energy from ocean waves into electricity. As a result, Mocean Energy enables customers to access reliable and affordable renewable energy to power various subsea applications, including control systems, remotely operated vehicles, and autonomous underwater vehicles.
Navenio
Grant in 2020
Navenio Limited is a software technology company based in Oxford, United Kingdom, that specializes in location-based services for indoor environments. Founded in 2015, Navenio offers a mobile application solution that enhances indoor localization by enabling the tracking of individuals without the need for additional hardware, such as beacons or Wi-Fi. This innovative approach utilizes fingerprinting of the electromagnetic spectrum, sensor data, and indoor mapping to provide accurate location monitoring across various sectors, including retail, transportation, venues, and healthcare. Navenio's intelligent workforce solution significantly improves operational efficiency and workflow by automating processes based on real-world best practices.
Torsion Information Security
Grant in 2020
Torsion Information Security Ltd. is a London-based company founded in 2013 that specializes in software solutions aimed at managing insider security risks for businesses. The company's offerings include tools for controlling insider threats, streamlining regulatory compliance, and managing permissions within SharePoint and other collaboration systems. Torsion's approach emphasizes empowering business users to control access to sensitive information, rather than relying solely on IT departments. This enables organizations to maintain visibility and control over data access as it evolves, addressing security and compliance challenges associated with widespread file sharing. Torsion's solutions integrate seamlessly with platforms such as Microsoft Teams, SharePoint, Office 365, and various file-sharing systems, making them suitable for businesses across finance, investment, professional services, and the public sector. The cloud-first design of Torsion's software ensures ease of deployment and affordability for organizations of all sizes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.